Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?

다국어 초록 (Multilingual Abstract)

Hypertriglyceridemia is caused by defects in triglyceride metabolism and generally manifests as abnormally high plasma triglyceride levels. Although the role of hypertriglyceridemia may not draw as much attention as that of plasma cholesterol in stroke, plasma triglycerides, especially nonfasting triglycerides, are thought to be correlated with the risk of ischemic stroke. Hypertriglyceridemia may increase the risk of ischemic stroke by promoting atherosclerosis and thrombosis and increasing blood viscosity. Moreover, hypertriglyceridemia may have some protective effects in patients who have already suffered a stroke via unclear mechanisms. Therefore, further studies are needed to elucidate the role of hypertriglyceridemia in the development and prognosis of ischemic stroke.

참고문헌 (Reference)

1 Holmes MV, "lipoproteins, and metabolites and risk of myocardial infarction and stroke" 71 : 620-632, 2018

2 Glasser SP, "What is the association of lipid levels and incident stroke" 220 : 890-894, 2016

3 Anxin Wang ; Haibin Li ; Jinhuan Yuan ; Yingting Zuo ; Yijun Zhang ; Shouhua Chen ; Shouling Wu ; Yongjun Wang, "Visit-to-Visit Variability of Lipids Measurements and the Risk of Stroke and Stroke Types: A Prospective Cohort Study" 대한뇌졸중학회 22 (22): 119-129, 2020

4 Dichtl W, "Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells" 84 : 1085-1094, 1999

5 Rapp JH, "Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque" 14 : 1767-1774, 1994

6 Wang L, "Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation" 50 : 204-213, 2009

7 Deng QW, "Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke" 24 : 283-291, 2017

8 Lee JS, "Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status : the strong heart study" 40 : 529-537, 2017

9 Listenberger LL, "Triglyceride accumulation protects against fatty acid-induced lipotoxicity" 100 : 3077-3082, 2003

10 Lundman P, "Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease" 96 : 3266-3268, 1997

11 Chan P, "Thrombophilia in patients with hypertriglyceridemia" 4 : 425-429, 1997

12 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report" 106 : 3143-3421, 2002

13 Harrison CM, "The use of regional anaesthetic blockade in a child with recurrent erythromelalgia" 88 : 65-66, 2003

14 Deng QW, "The short-term prognostic value of the triglyceride-to-high-density lipoprotein cholesterol ratio in acute ischemic stroke" 9 : 498-506, 2018

15 Wang L, "The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation" 57 : 1328-1339, 2008

16 Morimoto S, "The renin-angiotensin system is involved in the production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants" 26 : 315-323, 2003

17 Anderson RA, "The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes" 154 : 475-483, 2001

18 Liu X, "The associations of lipids and lipid ratios with stroke: a prospective cohort study" 21 : 127-135, 2019

19 Ebinger M, "The Berlin ‘Cream&Sugar’ Study : the prognostic impact of an oral triglyceride tolerance test in patients after acute ischaemic stroke" 5 : 126-130, 2010

20 Pepys MB, "Targeting C-reactive protein for the treatment of cardiovascular disease" 440 : 1217-1221, 2006

21 Leonhardt H, "Studies of plasma viscosity in primary hyperlipoproteinaemia" 28 : 29-40, 1977

22 Castilla-Guerra L, "Statins in the secondary prevention of stroke : new evidence from the SPARCL Study" 28 : 202-208, 2016

23 Aznaouridis K, "Statins in stroke" 26 : 6174-6185, 2019

24 Abe Y, "Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion" 18 : 723-731, 1998

25 Chen Y, "Severe hypertriglyceridemia does not protect from ischemic brain injury in gene-modified hypertriglyceridemic mice" 1639 : 161-173, 2016

26 Patel A, "Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region" 110 : 2678-2686, 2004

27 Boullart AC, "Serum triglycerides and risk of cardiovascular disease" 1821 : 867-875, 2012

28 Ohni M, "Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1" 2 (2): S41-S46, 1995

29 Nordestgaard BG, "Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo: molecular size as a determinant of fractional loss from the intima-inner media" 15 : 534-542, 1995

30 Stiko-Rahm A, "Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein" 10 : 1067-1073, 1990

31 Hindy G, "Role of blood lipids in the development of ischemic stroke and its subtypes : a Mendelian randomization study" 49 : 820-827, 2018

32 Kivioja R, "Risk factors for early-onset ischemic stroke : a case-control study" 7 : e009774-, 2018

33 Röther J, "Risk factor profile and management of cerebrovascular patients in the REACH Registry" 25 : 366-374, 2008

34 Gudmundsson GS, "Resistance vessel endothelial function in healthy humans during transient postprandial hypertriglyceridemia" 85 : 381-385, 2000

35 Saeed A, "Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease" 72 : 156-169, 2018

36 Huang YQ, "Relationship between triglyceride levels and ischaemic stroke in elderly hypertensive patients" 96 : 128-133, 2020

37 Bloomfield Rubins H, "Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol:the Veterans Affairs HDL Intervention Trial (VA-HIT)" 103 : 2828-2833, 2001

38 Tziomalos K, "Prognostic significance of major lipids in patients with acute ischemic stroke" 32 : 395-400, 2017

39 Zhao Y, "Prognosis and associated factors among elderly patients with small artery occlusion" 9 : 15380-, 2019

40 Silveira A, "Postprandial triglycerides and blood coagulation" 109 : S527-S532, 2001

41 Bae JH, "Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress" 155 : 517-523, 2001

42 Byberg L, "Plasminogen activator inhibitor-1 and relations to fatty acid composition in the diet and in serum cholesterol esters" 21 : 2086-2092, 2001

43 Sironi L, "Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL" 16 : 89-96, 1996

44 Késmárky G, "Plasma viscosity : a forgotten variable" 39 : 243-246, 2008

45 Nagashima H, "Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects" 26 : 428-434, 2011

46 Hassing HC, "Pathophysiology of hypertriglyceridemia" 1821 : 826-832, 2012

47 Kuriakose D, "Pathophysiology and treatment of stroke : present status and future perspectives" 21 : 7609-, 2020

48 Varbo A, "Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population" 69 : 628-634, 2011

49 Freiberg JJ, "Nonfasting triglycerides and risk of ischemic stroke in the general population" 300 : 2142-2152, 2008

50 Stamler J, "Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial" 1 : e003640-, 2012

51 Cui Q, "Modifiable and non-modifiable risk factors in ischemic stroke : a meta-analysis" 19 : 2121-2129, 2019

52 Alberici LC, "Mitochondrial energy metabolism and redox responses to hypertriglyceridemia" 43 : 19-23, 2011

53 Tikhomirova IA, "Microcirculation and blood rheology in patients with cerebrovascular disorders" 49 : 295-305, 2011

54 Brola W, "Metabolic syndrome in Polish ischemic stroke patients" 24 : 2167-2172, 2015

55 Liu L, "Metabolic syndrome and the short-term prognosis of acute ischemic stroke : a hospital-based retrospective study" 14 : 76-, 2015

56 Nicolson GL, "Metabolic syndrome and mitochondrial function : molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function" 100 : 1352-1369, 2007

57 Furie B, "Mechanisms of thrombus formation" 359 : 938-949, 2008

58 Dziedzic T, "Lower serum triglyceride level is associated with increased stroke severity" 35 : e151-e152, 2004

59 Weir CJ, "Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke" 16 : 76-82, 2003

60 Ren Y, "Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes : a cross-sectional survey in China" 34 : e2960-, 2018

61 Eiselein L, "Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis" 292 : H2745-H2753, 2007

62 Schwartz EA, "Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis" 1821 : 858-866, 2012

63 Mitropoulos KA, "Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII : a study in familial lipoprotein-lipase deficiency" 95 : 119-125, 1992

64 Berger JS, "Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women" 43 : 958-966, 2012

65 Negri M, "Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels" 99 : 55-61, 1993

66 Nordestgaard BG, "Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits" 29 : 1491-1500, 1988

67 Morrison AC, "LPL polymorphism predicts stroke risk in men" 22 : 233-242, 2002

68 Campbell BC, "Ischaemic stroke" 5 : 70-, 2019

69 Li X, "Is metabolic syndrome associated with the risk of recurrent stroke : a meta-analysis of cohort studies" 26 : 2700-2705, 2017

70 Scirica BM, "Is C-reactive protein an innocent bystander or proatherogenic culprit? : the verdict is still out" 113 : 2128-2134, 2006

71 Verma S, "Is C-reactive protein an innocent bystander or proatherogenic culprit? : C-reactive protein promotes atherothrombosis" 113 : 2135-2150, 2006

72 Proctor SD, "Intimal retention of cholesterol derived from apolipoprotein B100-and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits" 23 : 1595-1600, 2003

73 Wilhelm MG, "Induction of atherosclerosis by human chylomicron remnants : a hypothesis" 10 : 132-139, 2003

74 Nichols GA, "Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol" 21 : 366-371, 2019

75 Nichols GA, "Increased cardiovascular risk in hypertriglyceridemic patients with statin-controlled LDL cholesterol" 103 : 3019-3027, 2018

76 Yunoki K, "Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease" 108 : 333-339, 2011

77 Maeno Y, "IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells" 48 : 127-138, 2000

78 Hiraga T, "Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system" 28 : 603-606, 1996

79 Rosenson RS, "Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson : triglycerides and blood viscosity" 161 : 433-439, 2002

80 Mussoni L, "Hypertriglyceridemia and regulation of fibrinolytic activity" 12 : 19-27, 1992

81 Antonios N, "Hypertriglyceridemia and ischemic stroke" 60 : 269-278, 2008

82 Simpson HC, "Hypertriglyceridaemia and hypercoagulability" 1 : 786-790, 1983

83 Andersen P, "Hypercoagulability and reduced fibrinolysis in hyperlipidemia : relationship to the metabolic cardiovascular syndrome" 20 (20): S29-S31, 1992

84 Pikija S, "Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans" 55 : 89-92, 2006

85 Hennig B, "High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis" 20 (20): 97-105, 2001

86 Toth PP, "High triglycerides are associated with increased cardiovascular events, medical costs, and resource use : a real-world administrative claims analysis of statin-treated patients with high residual cardiovascular risk" 7 : e008740-, 2018

87 Nakamura T, "High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis" 202 : 234-240, 2009

88 Kang K, "High nonfasting triglyceride concentrations predict good outcome following acute ischaemic stroke" 39 : 779-786, 2017

89 Cooper AD, "Hepatic uptake of chylomicron remnants" 38 : 2173-2192, 1997

90 Zhao T, "Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia" 341 : 1066-1071, 2006

91 Smith WS, "Harrison’s Principles of Internal Medicine" McGraw-Hill 3270-3299, 2012

92 Goldstein LB, "Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke Association" 42 : 517-584, 2011

93 Kernan WN, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline for healthcare professionals from the American Heart Association/American Stroke Association" 45 : 2160-2236, 2014

94 Celap I, "Genetic and lifestyle predictors of ischemic stroke severity and outcome" 40 : 2565-2572, 2019

95 Jeng JR, "Gemfibrozil treatment of hypertriglyceridemia : improvement on fibrinolysis without change of insulin resistance" 134 : 565-571, 1997

96 Lupattelli G, "Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles" 140 : 521-526, 2000

97 Ridker PM, "Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk : do we need to revisit the oral triglyceride tolerance test" 54 : 11-13, 2008

98 Bansal S, "Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women" 298 : 309-316, 2007

99 Iso H, "Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: the Circulatory Risk in Communities Study (CIRCS)" 237 : 361-368, 2014

100 Tada H, "Fasting and non-fasting triglycerides and risk of cardiovascular events in diabetic patients under statin therapy" 84 : 509-515, 2020

101 Kaneko T, "Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins" 5 : 385-392, 1994

102 Lewis TV, "Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol" 33 : 805-812, 1999

103 Benítez MB, "Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia" 197 : 679-687, 2008

104 Schunkert H, "Elevated C-reactive protein in atherosclerosis : chicken or egg" 359 : 1953-1955, 2008

105 Ryu WS, "Effects of low serum triglyceride on stroke mortality : a prospective follow-up study" 212 : 299-304, 2010

106 Seplowitz AH, "Effects of lipoproteins on plasma viscosity" 38 : 89-95, 1981

107 Tholstrup T, "Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men" 77 : 1125-1132, 2003

108 Vogel RA, "Effect of a single highfat meal on endothelial function in healthy subjects" 79 : 350-354, 1997

109 Sultan S, "Dyslipidemia in children with arterial ischemic stroke : prevalence and risk factors" 78 : 46-54, 2018

110 Xu T, "Dyslipidemia and outcome in patients with acute ischemic stroke" 27 : 106-110, 2014

111 Imaizumi K, "Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins" 19 : 712-722, 1978

112 Tramacere I, "Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack : a systematic review and network meta-analysis" 17 : 67-, 2019

113 Carvalho de Sousa J, "Coagulation factor VII and plasma triglycerides : decreased catabolism as a possible mechanism of factor VII hyperactivity" 19 : 125-130, 1989

114 Park SY, "Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation" 312 : 1241-1248, 2005

115 Domoto K, "Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells" 171 : 193-200, 2003

116 Kawasaki S, "Chylomicron remnant induces apoptosis in vascular endothelial cells" 902 : 336-341, 2000

117 Kashyap SR, "Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effects" 3 : 141-146, 2008

118 Zernecke A, "Chemokines in atherosclerosis : an update" 28 : 1897-1908, 2008

119 Sun L, "Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults" 25 : 569-574, 2019

120 Bhatt DL, "Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia" 380 : 11-22, 2019

121 Gower RM, "CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1" 31 : 160-166, 2011

122 Lowe GD, "Blood viscosity and risk of cardiovascular events : the Edinburgh Artery Study" 96 : 168-173, 1997

123 Lee AJ, "Blood viscosity and elevated carotid intima-media thickness in men and women : the Edinburgh Artery Study" 97 : 1467-1473, 1998

124 Kawakami A, "Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions" 91 : 263-271, 2002

125 Mahley RW, "Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing" 117 : 94-98, 2007

126 Zilversmit DB, "Atherogenesis : a postprandial phenomenon" 60 : 473-485, 1979

127 Deng Q, "Association of serum lipids with clinical outcome in acute ischaemic stroke : a systematic review and meta-analysis" 59 : 236-244, 2019

128 Gu X, "Association of lipids with ischemic and hemorrhagic stroke : a prospective cohort study among 267 500 Chinese" 50 : 3376-3384, 2019

129 Lee H, "Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: a nationwide cohort study" 27 : 870-881, 2020

130 Toth PP, "Association of elevated triglycerides with increased cardiovascular risk and direct costs in statin-treated patients" 94 : 1670-1680, 2019

131 Munshi A, "Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes" 318 : 51-54, 2012

132 Mori Y, "Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima-media thickness (IMT) in Japanese patients with type 2 diabetes: assessment by meal tolerance tests (MTT)" 28 : 157-163, 2005

133 Shin DW, "Association between hypertriglyceridemia and lacunar infarction in type 2 diabetes mellitus" 24 : 1873-1878, 2015

134 Vayá A, "Association between hemorheological alterations and metabolic syndrome" 49 : 493-503, 2011

135 Labreuche J, "Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis : systematic review and meta-regression analysis" 212 : 9-15, 2010

136 Sacco RL, "Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke" 359 : 1238-1251, 2008

137 Hu F, "Asf1 links Rad53 to control of chromatin assembly" 15 : 1061-1066, 2001

138 Pi Y, "Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels : a meta-analysis" 33 : 558-565, 2012

139 Daugherty A, "Aortic accumulation and plasma clearance of beta-VLDL and HDL : effects of diet-induced hypercholesterolemia in rabbits" 26 : 955-963, 1985

140 Adibhatla RM, "Altered lipid metabolism in brain injury and disorders" 49 : 241-268, 2008

141 Boquist S, "Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men" 100 : 723-728, 1999

142 Minnema MC, "Activation of the contact system of coagulation does not contribute to the hemostatic imbalance in hypertriglyceridemia" 19 : 2548-2553, 1999

143 De Man FH, "Activated platelets in patients with severe hypertriglyceridemia : effects of triglyceride-lowering therapy" 152 : 407-414, 2000

144 Wang W, "A prospective study of the hypertriglyceridemic waist phenotype and risk of incident ischemic stroke in a Chinese rural population" 138 : 156-162, 2018